baber/WOPTO huggingface dataset:
Patent NZ-528899-A (NZ)
Title: In-situ combustion for oil recovery
Inventor: COLES JOHN MATTHEW
IPC: E21B36/04
Filed: 2001-10-10
Abstract: A method and system for transmitting heat substantially by conduction into a hydrocarbon containing formation surrounding a heat injection well utilise oxidant supply and combustion gases exhaust conduits disposed in the wellbore of the heat injection well, wherein an oxidant, such as air, in injected through the oxidant supply conduit to a reaction zone in the formation in the vicinity of the heat injection well where at least a portion of the hydrocarbons in the formation are oxidized such that heat and combustion gases are generated, and at least a portion of the combustion gases are transmitted through the combustion gases exhaust conduit away from the reaction zone such that migration of combustion gases from the reaction zone into the hydrocarbon containing formation is inhibited.
Patent NZ-536162-A (NZ)
Title: RFID integrated circuit chip for bioassays
Inventor: LAI DERHSING
IPC: B01J19/00
Filed: 2003-03-25
Abstract: An integrated circuit chip for use in the assay of a substance includes a transponder 5 with a hard-wired read only tag 1 created by a photomask process and containing an index ID code, and elements such as modulator 2, analog front end 3 and antenna 4 to be able to transmit the ID code to a receiver in response to a radio interrogation signal. A substance is attached to the transponder that creates some form of signal from the assay. For example, an electrochemiluminescent moiety may be attached to the transponder and if the moiety is activated to produce a light signal during the assay the identity of the responsive moiety may be determined by reading the ID code from the transponder.
Patent NZ-538685-A (NZ)
Title: Imidazopyrazines as cyclin dependent kinase inhibitors
Inventor: PARUCH KAMIL
IPC: A61P35/00
Filed: 2003-09-19
Abstract: Disclosed is a compound of formula III or a pharmaceutically acceptable salt or solvate thereof wherein the substituents are as described in the specification. Also disclosed is the use of the above compound, optionally combined with an anti-cancer agent, for the manufacture of a medicament for treating one or more diseases associated with cyclin dependent kinase.
Patent NZ-542268-A (NZ)
Title: New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
Inventor: HWANG GYO-HYUN
IPC: C07D207/22
Filed: 2004-03-06
Abstract: Disclosed is a process for the preparation of 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulphonate, a key intermediate of quinolone antibiotics. According to the process, the total number of steps has been reduced to 3-4 steps, the solid separation is not required, and the use of costly chemicals, particularly (BOC)2O (t-butoxycarbonyl anhydride), several organic solvents and reactants is eliminated.
Patent NZ-542330-A (NZ)
Title: Multiple plasma generator hazardous waste processing system
Inventor: TSANGARIS ANDREAS V
IPC: A62D3/00
Filed: 2004-02-10
Abstract: A waste processing system is provided herein which entails the use of at least one fixed-position plasma arc generator (36) for primary processing and at least one moveable plasma arc generator (38) for secondary processing assistance and/or final condition of the slag prior to exit from the reactor vessel. This optimum processing environment is provided by control of reactor vessel configuration and real time control of processing characteristics to ensure maximum processing efficiency.
Patent NZ-544420-A (NZ)
Title: (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
Inventor: DELUCA HECTOR F
IPC: A61P17/06
Filed: 2004-07-07
Abstract: Disclosed is (20S)-1alpha-hydroxy-2-methylene-19-norvitamin D3 of the formula (I). Also disclosed is the use of (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 of formula (I) in the manufacture of a medicament for treating psoriasis, leukaemia, colon cancer, breast cancer, prostrate cancer, an autoimmune disease, an inflammatory disease, a skin condition or a metabolic bone disease where it is desired to maintain or increase bone mass.
Patent NZ-544680-A (NZ)
Title: A system and method for identification of animals and secure storage of organic material taken from said animal
Inventor: CONNOLE MICHAEL JOHN
IPC: A01K11/00
Filed: 2004-08-09
Abstract: A system for identification of animals is disclosed. The system includes an animal identification device (12, 13) adapted for application to an animal and a device (17) for secure storage of organic material taken from the animal to be identified by the identification device. The storage device (17) and identification device (12, 13) are each marked with a common identifier (18, 18a). The identification device (12, 13) and the storage device (17) are mounted, prior to use, in a holder (1) which can be in the form of a moulded tray.
Patent NZ-547869-A (NZ)
Title: Recessed lighting fixture
Inventor: ENGEL HARTMUT S
IPC: F21V7/00
Filed: 2004-11-26
Abstract: A built-in lamp having a holder for fastening in an installation surface 1 having an illuminant fitting and having a reflector, wherein the holder and the reflector are arranged relative to one another such that the reflector extends beyond the installation surface 1 in a main direction of illumination with a built-in lamp secured in the installation surface 1, with the reflector being coupled in this region extending beyond the installation surface 1 to a reflection element which extends perpendicular or at an angle to the main direction of illumination, is arranged outside the reflector and can be illuminated by light via the region lying between the installation surface 1 and the reflection element, wherein the reflector 5 is made translucent or transparent at least sectionally in its region extending beyond the installation surface 1 or is provided with openings; or in that, in addition to the reflector 5 an additional light discharge region is provided which surrounds the reflector at least regionally and via which the reflection element can be illuminated by a portion of the light.
Patent NZ-548530-A (NZ)
Title: Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
Inventor: ALMARIO GARCIA ANTONIO
IPC: C07D211/22
Filed: 2005-01-07
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification. The compounds are useful in preventing or treating a pathology in which endogenous cannabinoids and/or any other substrates metabolized by the enzyme FAAH are involved, such as acute or chronic pain, dizziness, vomiting, nausea, eating disorders, neurological and psychiatric pathologies, acute or chronic neurodegenerative diseases, epilepsy, sleep disorders, cardiovascular diseases, renal ischemia, cancers, disorders of the immune system, allergic diseases, parasitic, viral or bacterial infectious diseases, inflammatory diseases, osteoporosis, ocular conditions, pulmonary conditions, gastrointestinal diseases or urinary incontinence.
Patent NZ-548621-A (NZ)
Title: System and method for selecting a mattress and a pillow
Inventor: BOYD DENNIS M
Filed: 2006-07-18
Abstract: A system to assist a consumer in selecting a mattress with a fixed support structure equal to the consumer's desired support level comprises: a plurality of mattresses with fixed support structures; and a diagnostic mattress with an adjustable support structure having a controller for selectively adjusting the adjustable support structure in accordance with a desired level of support as determined by a subject positioned on the diagnostic mattress. Each of the plurality of mattresses has a support characteristic representative of the fixed support structure. The controller is adapted to generate a report correlating the subject's desired support level to a support characteristic of a fixed support structure of a mattress in the plurality of mattresses thereby allowing the subject to select a mattress with a fixed support structure support characteristic generally equal to the subject's desired support level as determined from the diagnostic mattress based upon the report.
Patent NZ-549195-A (NZ)
Title: Apparatus for mixing and discharging bone cement
Inventor: FOSTER DAVID
IPC: A61F2/46
Filed: 2005-03-08
Abstract: An apparatus for mixing and discharging bone cement compounds includes a container with first and second ends 14, 16 on a longitudinal axis L, a mixing region 13, at least one exit port 20 and a valve 30 for controlling communication of material between the mixing region 13 and the exit port 20 of discharge region. The exit port 20 into which a collection syringe 19 can be mated is located between the first and second ends and the valve 30 is movable along the axis between a first closed position and a second open position that permits material to move from the mixing chamber to the exit port. The apparatus includes a base 440 on which the apparatus can be freestanding and which can be rotated to cause axial movement of the valve between the closed and open positions.
Patent NZ-549855-A (NZ)
Title: Improvements in screens and methods of their manufacture
Inventor: FORRESTER NEIL
Filed: 2006-09-12
Abstract: Screens with particular application as filters in a downpipe, and methods for their manufacture are disclosed. The screen (1) has a plurality of channels (7) that pass from an upstream side to a downstream side, where the openings of the channels on the upstream side are larger than the openings of the respective channels on the downstream side. More than 50% of the surface area of the upstream side is occupied by channel openings. In use, the screen is positioned on an incline in a fluid flow to separate out debris from the flow.
Patent NZ-549880-A (NZ)
Title: Azaindoles useful as inhibitors of JAK and other protein kinases
Inventor: SALITURO FRANCESCO
IPC: C07D471/04
Filed: 2005-03-30
Abstract: Disclosed is a compound of formula (IB) or pharmaceutically acceptable salts thereof wherein the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula (IB) in the manufacture of a medicament for inhibiting JAK-3, ROCK or Aurora kinase activity.
Patent NZ-551914-A (NZ)
Title: Implant assembly device
Inventor: POWELL SEAN
IPC: A61B17/88
Filed: 2005-05-31
Abstract: This disclosure relates generally to systems for the internal fixation of bone fractures, and particularly, to equipment associated with the insertion of intramedullary fracture fixation devices such as those used in the treatment of long bone fractures, such as for example fractures of the femur, tibia, humerus, etc. An implant assembly device of the present invention may comprise a handle, a shaft with a first end and a second end, and an elongated rod extending from the shaft. The first end of the shaft is connected to the handle and the second end of the shaft is configured to engage the head of a connecting screw. The device can be held with one hand while the various components are placed one by one into their proper position onto the rod, leaving the other hand free to manipulate the other components.
Patent NZ-554615-A (NZ)
Title: Compression device for a limb having a non-elastic sleeve to surround the limb and a cell on the inside of the sleeve having a box-like configuration adapted to conform to the shape of the limb when inflated
Inventor: LINNANE PATRICK GERARD
IPC: A61H23/04
Filed: 2005-10-21
Abstract: A compression device for a limb is disclosed. The compression device comprises a sleeve adapted to surround the limb, an inelastic layer, and an inflatable cell. The sleeve comprises an inelastic layer and a cell constructed from an inner part joined to an outer part by one or more side walls so that the cell has a box-like configuration. The inner part conforms to the shape of the limb when the cell is inflated to provide an even pressure to the limb. The inner part is elastic and is able to adopt the profile of the limb on inflation.
Patent NZ-561237-A (NZ)
Title: 8-Phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
Inventor: BOEHM JEFFREY C
IPC: A61K31/519
Filed: 2006-03-24
Abstract: Disclosed are the compounds: 3-[2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yI]-5-fluoro-4-methyl-N-(1-methylethyl)benzamide;N-cyclopropyl-3-[2-{[3-(diethylamino) propyl]amino}-8-(2,6-difluorophenyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yl]-5-fluoro-4-methylbenzamide, and 3-{8-(2,6-difluorophenyl)-2-[(1H-imidazol-2-ylmethyl)amino]-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-4-yI}-4-methyl-N-1,3-thiazol-2-yIbenzamide. Also more generally disclosed are compounds of the pictured formula where the substituents are as described in the specification. Also disclosed are the use of the compounds in medicaments.
Patent NZ-562814-A (NZ)
Title: A pipe fitting
Inventor: EYLEY BRIAN
Filed: 2007-10-25
Abstract: A pipe coupling (10) that can be used to couple two or more parallel pipes (62) to a single pipe is disclosed. The fitting has a body with a pipe coupling arrangement (18) at one end, and at least two further pipe coupling arrangements (52) at an opposite end. The further pipe coupling arrangements include coupling formations (20, 24, 26) that are closed off by blank walls which can be opened to enable a pipe to be coupled to a coupling formation. This allows a selected number of pipes to be coupled to the fitting.
Patent NZ-565337-A (NZ)
Title: Using cytosine deaminases to diminish retroelement transfer from pigs to humans
Inventor: HARRIS REUBEN S
IPC: C12N5/07
Filed: 2006-06-22
Abstract: Provided is a transgenic pig, the nucleated cells of which comprise a nucleic acid construct expressing non-porcine cytosine deaminase polypeptide, giving decreased capability to transmit porcine endogenous retroviruses to human cells. Further provided are tissues and cells from such pigs.
Patent NZ-574447-A (NZ)
Title: Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
Inventor: MANNION RICHARD OWEN
IPC: A61K9/32
Filed: 2007-08-24
Abstract: Disclosed is a process of preparing a solid oral extended release pharmaceutical dosage form, comprising combining (a) combining (1) at least one polyethylene oxide and (2) at least one active agent selected from i) opioid analgesics ii) therapeutically active agents iii) combinations of i) and ii); and iv) benzodiazepines, barbiturates, amphetamines, stimulants, combinations with respective antagonists, pharmaceutically acceptable salts, hydrates, and solvates and mixtures thereof to form a composition; (b) shaping the composition to form an extended release matrix formulation; and (c) curing said extended release matrix formulation
Patent NZ-575658-A (NZ)
Title: Person carrier with handles and belts
Inventor: WONG CHO KEE
IPC: A61G1/013
Filed: 2007-05-10
Abstract: A rescuing and carrying device A, comprises a supporting portion 1, shoulder belts 5, at least one pair of handhold belts 2 and safety belts 3, all of which are made of flexible materials. The supporting portion 1 is shaped like a sheet or a bag. The shoulder belts 5 and the safety belts 3 are fixed on the supporting portion 1. The handhold belts 2, which are fixed on the side borders of the supporting portion 1, are spaced apart from each other.
Patent NZ-576174-A (NZ)
Title: Novel antiproliferation antibodies
Inventor: GOETSCH LILIANE
IPC: C12N5/20
Filed: 2007-11-23
Abstract: Disclosed is an isolated antibody, or a functional Fragment of same, capable of inhibiting the proliferation of tumor cells in vitro and/or in vivo, characterized in that it comprises the CDRs of sequences comprising SEQ ID NOs: 1 (QDINNY), 2 (TDYS), 3 (YTS), 4 (IDPYNGGT), 5 (LQYDNLWT) and 6 (QTDYFDY).
Patent NZ-583831-A (NZ)
Title: Protein-polymer conjugates comprising interferon-alpha
Inventor: LIN KO-CHUNG
IPC: A61K47/48
Filed: 2008-08-15
Abstract: Disclosed are protein-polymer conjugates comprising a polymer, a protein and a linker, wherein the protein is interferon-alpha which has 1-4 additional amino acid residues at the N-terminus. The conjugates are used to treat hepatitis B or C virus infection.
Patent NZ-586261-A (NZ)
Title: Container for smoking articles with two connected packs with hinged lids
Inventor: BARDET PIERRE-ALAIN
IPC: B31B50/62
Filed: 2008-12-18
Abstract: A container (2) comprises two or more connected packs (4, 6), at least one for housing a bundle of smoking articles. The container comprises a first pack (4) formed of one or more laminar blanks and having a first wall; and a second, hinge-lid pack (6) formed of one or more laminar blanks and comprising a box part (14) and a lid (16) connected to the box part (14) along a hinge line extending across a back wall of the second pack (6). The laminar blanks for forming the first pack are separate from the laminar blanks for forming the second pack. A wall of the lid (16) of the second pack is affixed to the first wall of the first pack (4).
Patent NZ-586955-A (NZ)
Title: Novel process for the preparation of vorinostat
Inventor: GAITONDE ABHAY
IPC: A61K31/167
Filed: 2009-02-06
Abstract: Disclosed is a process for the preparation of vorinostat, comprising the following steps: (a) reaction of suberic acid with a haloformate such as methyl chloroformate in the presence of a base such as triethylamine (thereby resulting in an insoluble precipitate of triethylammonium chloride which can be removed by filtration); (b) reaction of aniline with the product of step (a); (c) reaction of a haloformate with the product of step (b) in the presence of a base (i.e. another equivalent of methyl chloroformate / triethylamine); (d) reaction of hydroxylamine with the product of step (c); and (e) isolation of the product vorinostat; wherein the reaction is desirably conducted in an organic solvent selected from the group comprising dimethyl sulfoxide, tetrahydrofuran, acetonitrile, dimethylformamide or dimethyl acetamide; and wherein steps (a)-(d) can be conducted sequentially without isolation of the corresponding intermediates (i.e. in a one pot synthesis). Also disclosed is high purity vorinostat obtained by the above process. Suitable uses of vorinostat are also disclosed. .
Patent NZ-590168-A (NZ)
Title: Conversion of vegetable oils to base oils and transportation fuels
Inventor: MILLER STEPHEN J
IPC: C10G3/00
Filed: 2009-07-22
Abstract: Disclosed is a method for producing base oil and diesel fuel, the method comprising the steps of: a) providing a triglyceride-containing vegetable oil comprising both saturated and unsaturated fatty acid components; b) processing the triglyceride-containing vegetable oil to effect deoxygenation of saturated fatty acid components and oligomerization and deoxygenation of unsaturated fatty acid components contained therein so as to provide for an oligomerized mixture comprising an oligomer component, wherein said processing comprises hydrotreating and subsequent water removal; c) isomerizing the oligomerized mixture over an isomerization catalyst to yield an isomerized mixture; wherein the isomerized mixture comprises (i) a base oil component derived from oligomerization and deoxygenation of the unsaturated fatty acid components, and (ii) a diesel fuel component derived from the deoxygenation of the saturated fatty acid components; and wherein the isomerized mixture comprises at least 10 wt. per cent oligomers as alkanes having a carbon number of 30 or greater and contributing to the base oil component of the isomerized mixture; and d) distilling the isomerized mixture to yield a base oil and a diesel fuel. Also disclosed is a system for carrying out the method and a base oil and diesel fuel when obtained by the process.
Patent NZ-590497-A (NZ)
Title: Hard surface cleaning composition for personal contact areas
Inventor: GAUDREAULT ROSEMARY A
IPC: C11D1/00
Filed: 2011-01-13
Abstract: A hard surface cleaning solution consisting essentially of: an organic acid comprising a carboxylic acid selected from the group consisting of lactic acid, formic acid, citric acid and acetic acid; wherein the organic acid is present in the solution in an amount of about 5.0 wt. per cent to about 10.0 wt. per cent of the active cleaning composition; a surfactant selected from the group consisting of amine oxides such as lauamine oxide; a solvent selected from the group consisting of ether alcohols such as propylene glycol (mono) butyl ether; and a diluent; wherein the solution has a pH of at least 2.0.
Patent NZ-591560-A (NZ)
Title: Method and Apparatus for Awarding at least one Jackpot Prize
Inventor: WRIGHT DEAN
IPC: A63F13/12
Filed: 2011-03-07
Abstract: A controller (1) and a method for awarding at least one jackpot prize are disclosed. The controller has a processor (2); a memory (6) operatively coupled to the processor; and communication means (3) for communication with the plurality of electronic gaming machines (4). The controller is programmed to define parameters for a first jackpot with the parameters including an award criterion; define parameters for a second jackpot with the parameters including a storage criterion; accumulate a first jackpot prize pool in dependence upon a gaming activity of a plurality of electronic gaming machines; accumulate a second jackpot prize pool in dependence upon said gaming activity; store the second jackpot prize pool as a pending jackpot prize, re-define the second jackpot storage criterion and reset the second jackpot prize pool in response to a satisfaction of the storage criterion; and award the first jackpot prize pool and one or more of any pending jackpot prizes to at least one recipient in accordance with a jackpot prize distribution scheme in response to a satisfaction of the award criterion. Also disclosed is a gaming system including a plurality of electronic gaming machines and the above described controller in communication with said plurality of gaming machines.
Patent NZ-592608-A (NZ)
Title: Benzoxazole kinase inhibitors and methods of use
Inventor: CHAN KATRINA
IPC: A61K31/4162
Filed: 2009-11-02
Abstract: 592608 Disclosed are 4-amino-pyrazolo[3,4-d]pyrimidine derivatives as represented by the general formula II-A-1, or a pharmaceutically acceptable salt thereof, wherein: X1 and X2 are N; R1 is hydrogen, -L-alkyl, -L-cycloalkyl, -L-alkylheterocyclyl, -L-heteroalkyl, or -L-heterocyclyl, each of which is unsubstituted or substituted by one or more independent R3 substituents; L is a bond, C=O, -C(=O)O-, -C(=O)N(R31)-, -S-, -S(O)-, -S(O)2-, -S(O)2N(R31)-, or -N(R31)-; E2 is H; each of R31 and R32 are independently H or unsubstituted alkyl; wherein heterocyclyl is a substituted or unsubstituted 3-, 4-, 5-, or 6- membered saturated or partially unsaturated ring containing one, two, or three heteroatoms independently selected from oxygen, nitrogen and sulfur; or to a bicyclic ring system containing up to 10 atoms including at least one heteroatom independently selected from oxygen, nitrogen, and sulfur wherein the ring containing the heteroatom is saturated; and wherein the remaining substituents are as defined herein. Representative compounds include 4-amino-1-(1-hydroxy-2-methyl-propan-2-yl)-3-(2-amino-1,3-benzoxazol-5-yl)-pyrazolo[3,4-d]pyrimidine. Also disclosed is a pharmaceutical composition which comprises a compound or pharmaceutically acceptable salt as defined above, and further comprising a pharmaceutical excipient, for inhibiting activity of a protein kinase and/or a lipid kinase present in a cell, such as mTor, and for the treatment of cancer, bone disorder, inflammatory disease, immune disease, nervous system disease, metabolic disease, respiratory disease, and cardiac disease.